Evexia Lifecare Limited announced the approval of its unaudited financial results for the quarter ended June 30, 2026, during a board meeting held on August 7, 2026. The disclosure, made pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirms that the company’s financial performance for Q1FY27 has been reviewed by its statutory auditors. Investors seeking detailed metrics can access the full financial statements and the limited review report via the company’s website or through the Quick Response (QR) code provided in the official filing.

The approval process followed standard corporate governance protocols, with the Audit Committee recommending the results to the Board of Directors prior to ratification. Jayesh Raichandbhai Thakkar, Chairman and Managing Director of Evexia Lifecare Limited, signed off on the announcement from Vadodara. The company simultaneously published advertisements in Financial Express (English) and Financial Express (Gujarati) on August 8, 2026, to ensure broad dissemination among stakeholders.

Regulatory Compliance

The filing adheres to the SEBI Listing Regulations, specifically Regulations 30 and 47, which mandate timely disclosure of material events and financial results. The limited review report submitted by the statutory auditors provides assurance over the unaudited financial information presented for the quarter. This procedural step is critical for maintaining transparency and regulatory compliance for listed entities in India.

Key Details

What the Numbers Show

While the specific revenue and profit figures are contained within the linked financial statements rather than the press release text itself, the issuance of a limited review report indicates that the statutory auditors have completed their preliminary examination of the quarter’s accounts. For investors monitoring Evexia Lifecare Limited, the availability of these documents on the corporate website allows for immediate analysis of operational performance and balance sheet health for Q1FY27.

Kiran Kumar Jain M. has increased his shareholding in Evexia Lifecare Limited to 5.86% following the acquisition of 1,00,000 shares. The transaction was executed via an open market purchase on June 15, 2026, as disclosed to the Bombay Stock Exchange.

The acquisition was made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Prior to this purchase, the acquirer held 10,99,00,000 shares, which represented 5.85% of the total voting capital. The additional 1,00,000 shares acquired account for 0.01% of the total share capital.

The total equity share capital and total voting capital of Evexia Lifecare Limited remain at Rs. 187.73 Crores both before and after the acquisition. The acquirer does not belong to the promoter or promoter group of the target company.

Shareholding Details

The following table outlines the changes in shareholding following the transaction:

Transaction Particulars

The disclosure confirms that there were no warrants, convertible securities, or other instruments entitling the acquirer to receive shares carrying voting rights involved in this transaction. Additionally, there were no shares in the nature of encumbrance such as pledge or lien reported. The shares of Evexia Lifecare Limited are listed on BSE Limited.